OMRON Healthcare to launch operations in March 2025 at Origins by Mahindra in Chennai
The OMRON Healthcare factory will be built over 6.02 acres and will be manufacturing blood pressure monitors and supplying them mainly to the domestic market.
The OMRON Healthcare factory will be built over 6.02 acres and will be manufacturing blood pressure monitors and supplying them mainly to the domestic market.
The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing facilities in Europe.
For the treatment of Superficial Femoral Artery
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
Lonza launches the TheraPEAK T-VIVO Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors
The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Subscribe To Our Newsletter & Stay Updated